Specificity of Anti-dsDNA Antibodies for Systemic Lupus Erythematosus
Anti-dsDNA antibodies have very high specificity for systemic lupus erythematosus (SLE), with specificity rates ranging from 90-96% depending on the testing method used. 1, 2
Understanding Anti-dsDNA Testing Specificity
Anti-dsDNA antibodies are one of the most important immunological markers for SLE diagnosis and monitoring. Their specificity varies by testing method:
- ELISA (Enzyme-Linked Immunosorbent Assay): Specificity of approximately 90% 2
- ELiA (Fluorescence Immunoassay): Specificity of 95.9% 2
- CLIFT (Crithidia luciliae Immunofluorescence Test): Highest specificity, approaching 96-97% 1, 3
The high specificity makes anti-dsDNA antibodies valuable for SLE diagnosis, especially when combined with clinical features and other laboratory findings.
Testing Considerations and Interpretation
Testing Algorithm
- Start with ANA testing as an entry criterion (required to be positive at ≥1:80 titer by immunofluorescence for SLE classification) 1
- Follow positive ANA with anti-dsDNA testing using at least one method 1, 4
- Consider using multiple anti-dsDNA testing methods for increased specificity 3
- When both RIA and CLIA testing methods are positive in patients with homogeneous or speckled ANA patterns, specificity approaches 100% 3
Important Caveats
Despite high specificity, anti-dsDNA antibodies can occasionally be found in:
The term "anti-dsDNA" encompasses a heterogeneous group of antibodies with different specificities, not a single uniform entity 1
Optimizing Diagnostic Accuracy
To maximize diagnostic value:
Combine anti-dsDNA testing with ANA pattern analysis:
Consider using multiple testing methods:
Beyond Anti-dsDNA: Additional Testing Considerations
When anti-dsDNA results are negative but SLE is still suspected:
Anti-nucleosome antibodies may be useful, showing higher sensitivity (47.5% vs 37.5%) and specificity (95-100% vs 82.5-97.5%) than anti-dsDNA for SLE diagnosis 5
Anti-C1q antibodies are found in almost 100% of patients with active lupus nephritis and can help identify this complication 1
Anti-ENA antibodies (including Smith, Ro, La, and U1-ribonucleoprotein) should be tested when ANA is positive 1, 4
Clinical Correlation
Anti-dsDNA antibodies are not just diagnostic markers but also have clinical significance:
- Higher titers correlate with disease activity in many patients 6
- IgA anti-dsDNA isotype is particularly associated with lupus nephritis and active disease 7
- IgG/IgM ratio of anti-dsDNA antibodies is significantly higher in patients with more active disease 7
In conclusion, while anti-dsDNA antibodies have excellent specificity for SLE (90-96%), their interpretation should be considered alongside clinical presentation, ANA pattern, and potentially other autoantibodies for optimal diagnostic accuracy.